Medical Education
“I don’t know how many of these [medicines] are necessary..”—A focus group study among elderly users of multiple medicines

https://doi.org/10.1016/j.pec.2008.08.019Get rights and content

Abstract

Objective

The growing prevalence of multiple medicine use among elderly challenges health care. The aim was to conduct an exploratory study describing multiple medicine use from the elderly patient’s perspective.

Methods

Twelve focus groups of 29 men and 30 women 65 years of age or older, using five or more medicines were analysed qualitatively.

Results

Initially the participants reported no problems with using multiple medicines; they felt fortunate that medicines existed and kept them alive. However, negative attitudes were also revealed, both similar to those presented in studies on lay experience of medicine-taking and some that appear more specific to users of multiple medicines. The foremost of these was that acceptance of medicines depends on not experiencing adverse effects and worrying whether multiple medicine use is ‘good’ for the body. Furthermore, participants’ perception of their medicines depended on interaction with doctors, i.e. trusting ‘good’ doctors.

Conclusion

The participants revealed co-existing accounts of both immediate gratitude and problems with using multiple medicines. Furthermore, the patient–doctor relationship coloured their attitudes towards their medicines.

Practice implications

Importance of the patient–doctor relationship for treatment success is highlighted. Moreover, to be able to capture both accounts of the elderly in this study an appropriate consultation length is needed.

Introduction

There are widespread concerns about both extent and quality of medicine use by older people [1]. The average rate of non-adherence to chronic medication has been estimated at about 50% [2]. Multiple diseases and complex medicine regimes in elderly patients may compromise adherence even further [3], [4]. Studies of regimen simplification, like reduced dose frequency, often focus on patient adherence only and fail to include measures of satisfaction or acceptability by patients or show that simplification leads to clinical improvements [5], [6], [7], [8], [9].

The literature contains many studies on patients’ experiences of medicine-taking in general, among different patient groups [10], but few focus on elderly and/or users of multiple medicines [6], [11]. We know that medicines occupy a central place in the way people with high levels of chronic morbidity manage their diseases [6], [11]. Patients see medicines as unwelcome but necessary and having a routine is recognised as the key to coping with multiple medicine regimes. Results from a synthesis of qualitative studies of medicine-taking indicate considerable general reluctance to medicine use and a preference for using as little as possible [10]. The majority of studies focus on reasons for not taking medicines as prescribed based on the view that the norm is taking medicines as prescribed. Patients try out medicines and weigh risks and benefits; the occurrences of adverse effects are key criteria in their evaluations [12]. Furthermore, as medicine use is equated with having an illness, people who do not accept their illnesses are unlikely to accept their treatment, e.g. asthma patients [13].

Quality of medical care for elderly people is a national priority in Sweden and elsewhere [14], [15]. Limiting the number of unnecessary medicines has current priority, although attention to under-prescribing of beneficial medicines should not be neglected [16]. Important initiatives for improving treatment quality include the Beers criteria (1997), a list of 48 individual/classes of medicines to avoid and 20 conditions and medicines to be avoided in older people with these conditions [17], [18]. Other initiatives focus on adherence to Standard Treatment Guidelines [19] incorporating available evidence regarding a given disease and provide recommendations, including the use of multiple medicine regimens, for the treatment of patients with that disease. No one doubts their benefits, though what is less clear are the long-term net benefits and potential harm associated with multiple medicine use due to adherence to all different disease-specific guidelines relevant for patients with co-morbidity [20].

Patients are increasingly encouraged to take active roles in managing their health, expressing their concerns and preferences, and in participating in medical decision-making [21], [22]. There is little empirical research examining elderly patients’ perceptions of multiple medicine use. Increased knowledge of everyday experience with a multiple medicine regime is of great importance in improving quality of care and health outcomes for elderly patients.

The aim of this study was to conduct an exploratory study describing multiple medicine use from the elderly patient’s perspective.

Section snippets

Methods

The study was approved by the Regional Ethical Review Board at Uppsala University (Dnr. 2006:159).

Results

Because the same categories and subcategories emerged in separate analyses of men’s and women’s focus groups, we decided to merge the results. However, it is stated clearly when statements were made by only one of the genders under each subcategory. Three main categories with subcategories were generated by the focus group data (Table 1): Belief about medicines (A): ‘Attitude to medicines (A1)’, ‘Definition of multiple medicine use (A2)’, ‘Benefit from medicines (A3)’, and ‘Adverse effects and

Discussion

This study explored use of multiple medicines from the elderly patient’s perspective. The results reveal co-existing accounts of positive and negative attitudes to and experiences of being users of multiple medicines. The positive accounts found deviate from the existing literature on lay experience of medicine-taking, while the negative accounts confirm previous results [10]. Furthermore, the elderly participants’ experiences of being users of multiple medicines and their perceptions about

Acknowledgements

We would like to thank the elderly persons who volunteered to participate in this study for their time and contributions. This study was undertaken as part of a doctoral thesis supported by a grant from the Swedish Association for Senior Citizens (SPF), which we gratefully acknowledge. The funding source had no involvement in the research process. The authors have no competing interests to declare.

References (44)

  • J.T. Hanlon et al.

    Suboptimal prescribing in older inpatients and outpatients

    J Am Geriatr Soc

    (2001)
  • Adherence to long-term therapies. Evidence for action. In: Geneva: World Health Organization;...
  • I. Barat et al.

    Drug therapy in the elderly: what doctors believe and patients actually do

    Br J Clin Pharmacol

    (2001)
  • M.J. van Vliet et al.

    Improper intake of medication by elders—insights on contributing factors: a review of the literature

    Res Theory Nurs Pract

    (2006)
  • B. Girvin et al.

    A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance

    J Hypertens

    (1999)
  • B. Williams et al.

    Patient perspectives on multiple medications versus combined pills: a qualitative study

    Quart J Med

    (2005)
  • K. Schroeder et al.

    How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials

    Arch Intern Med

    (2004)
  • Detry J-MR et al.

    Patient compliance and therapeutic coverage: comparison of amlopidine and slow release nifedipine in the treatment of hypertension

    Eur J Clin Pharmacol

    (1995)
  • A. Townsend et al.

    Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use

    Brit Med J

    (2003)
  • Stimulansmedel för bättre vård och omsorg om äldre [Stimulation funds for better care for the elderly]. Stockholm:...
  • DoH

    National service framework for older people

    (2001)
  • P.A. Rochon et al.

    Prescribing for seniors. Neither too much nor too little

    J Am Med Assoc

    (1999)
  • Cited by (101)

    • Translation, cross-cultural adaptation, and validation of the Danish version of the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire: Version for older people with limited life expectancy

      2021, Research in Social and Administrative Pharmacy
      Citation Excerpt :

      The proposed model (model 3) showed acceptable construct validity. We failed to prove hypothesis 1 (that a higher ‘burden’ score would correlate positively with a higher Abbreviated Wake Forest Trust in Physician score) as well as hypothesis 5 and 8 (that a lower ‘concerns about stopping’ factor would correlate negatively with a higher BMQ Specific-Concerns score and a larger number of regular medications, respectively) (Appendix A); however, as mentioned above, a possible explanation for this may be the conflicting attitudes of older people.49–53 The principal strength of our study is the application of established guidelines and quality criteria for translation and cross-cultural adaptation as well as validation of the study,28,40 respectively.

    View all citing articles on Scopus
    View full text